Insulin resistance and insulin deficiency in the pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus : errors of metabolism or of methods
New pill options, discount programs, Medicare negotiations, and broader insurance coverage are making treatment more affordable
Methylene blue pretreatment inhibited S-nitroso-L-cysteine and sodium nitroprusside induced cyclic guanosine monophosphate accumulation by 51% to 100%, but S-nitroso-3-mercaptoproprionic acid mediated responses were not altered by methylene blue
manufacturers of FDA-approved semaglutide and tirzepatide, and that "they do not sell these medications for compounding." The FDA has published safety concerns specifically about compounded and unapproved GLP-1 products, including reports of adverse events
Women with PCOS burn fewer calories at rest, store fat more readily in the abdominal region, and have hormonal signaling that actively opposes weight loss efforts